ATORVASTATIN CALCIUM
- Product NDC
- 50090-5497
- 11-digit product format
- 500905497
- Labeler code
- 50090
- Product ID
- 50090-5497_cf99ea10-1a56-44e7-a832-962d41d46444
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA207687
- Marketing category
- ANDA
- Marketing start
- 2018-08-02
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5497-1 | 50090549701 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5497-1) | 2021-03-23 | 0000-00-00 | No | No | Current |